Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
Profitability Metrics
Gross Margin
200.08%
Operating Margin
59.46%
Net Margin
36.60%
Efficiency Metrics
Revenue per Expense Ratio
2.47
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
52.77%
Income Tax Rate
24.37%
EPS
7.4900000000
Balance Sheet Analysis
Current Ratio
20.01
Cash Ratio
20.01
Working Capital
$3.65B
Debt to Equity
0.91
Debt to Assets
6.96%
Equity Ratio
7.69%
Cash Flow Analysis
Operating Cash Flow Ratio
18.25%
Free Cash Flow Ratio
12.20%
CapEx to Revenue
6.05%
Dividends Paid
$14.64M
Stock Buybacks
$42.24M
Total Shareholder Returns
$56.88M
Cash Position Change
743.86%
Key Takeaways (2023 FY)
Revenue declined by 22.811854438751%, indicating potential market challenges
Increased dividend payments by 62.91%
Detailed Growth Metrics
Core Performance
Revenue
-22.81%
Net Income
-59.41%
EPS
-60.33%
Operating Income
-26.51%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
10,803.78%
Operating Cash Flow
698.94%
Free Cash Flow
435.28%
Balance Sheet Health
Assets
2.01%
Debt
31.99%
Book Value per Share
21.23%
Inventory
100.00%
Shareholder Returns
Dividends per Share
62.91%
Shares Outstanding
-3.67%
Long Term Trends
3Y Revenue/Share
26.07%
5Y Revenue/Share
64.21%
3Y Dividend/Share
4.21%
5Y Dividend/Share
1.66%